Milademetan Treatment A + Milademetan Treatment B + Milademetan Treatment C
Phase 1Completed 2 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Food Effects on Pharmacokinetics
Conditions
Food Effects on Pharmacokinetics
Trial Timeline
Aug 16, 2018 → Sep 13, 2018
NCT ID
NCT03647202About Milademetan Treatment A + Milademetan Treatment B + Milademetan Treatment C
Milademetan Treatment A + Milademetan Treatment B + Milademetan Treatment C is a phase 1 stage product being developed by Daiichi Sankyo for Food Effects on Pharmacokinetics. The current trial status is completed. This product is registered under clinical trial identifier NCT03647202. Target conditions include Food Effects on Pharmacokinetics.
What happened to similar drugs?
2 of 3 similar drugs in Food Effects on Pharmacokinetics were approved
Approved (2) Terminated (1) Active (0)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03647202 | Phase 1 | Completed |
Competing Products
17 competing products in Food Effects on Pharmacokinetics